255 related articles for article (PubMed ID: 15975099)
21. Enhanced algorithm for glucose estimation using the continuous glucose monitoring system.
Leal Y; Garcia-Gabin W; Bondia J; Esteve E; Ricart W; Fernández-Real JM; Vehí J
Med Sci Monit; 2010 Jun; 16(6):MT51-8. PubMed ID: 20512100
[TBL] [Abstract][Full Text] [Related]
22. Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.
Kaufman FR; Austin J; Neinstein A; Jeng L; Halvorson M; Devoe DJ; Pitukcheewanont P
J Pediatr; 2002 Nov; 141(5):625-30. PubMed ID: 12410189
[TBL] [Abstract][Full Text] [Related]
23. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
24. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
Guerci B; Floriot M; Böhme P; Durain D; Benichou M; Jellimann S; Drouin P
Diabetes Care; 2003 Mar; 26(3):582-9. PubMed ID: 12610005
[TBL] [Abstract][Full Text] [Related]
25. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
26. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
[TBL] [Abstract][Full Text] [Related]
27. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Simon B; Treat V; Marco C; Rosenberg D; Joseph J; Hipszer B; Li Y; Chervoneva I; Padron-Massara L; Jabbour S
Int J Clin Pract; 2008 Dec; 62(12):1858-63. PubMed ID: 19166434
[TBL] [Abstract][Full Text] [Related]
28. Continuous glucose monitoring in diabetic long distance runners.
Cauza E; Hanusch-Enserer U; Strasser B; Ludvik B; Kostner K; Dunky A; Haber P
Int J Sports Med; 2005 Nov; 26(9):774-80. PubMed ID: 16237624
[TBL] [Abstract][Full Text] [Related]
29. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy.
McLachlan K; Jenkins A; O'Neal D
Aust N Z J Obstet Gynaecol; 2007 Jun; 47(3):186-90. PubMed ID: 17550484
[TBL] [Abstract][Full Text] [Related]
30. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
[TBL] [Abstract][Full Text] [Related]
31. Continuous blood glucose monitoring in diabetes treatment.
Vazeou A
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S125-30. PubMed ID: 21864744
[TBL] [Abstract][Full Text] [Related]
32. Investigation on the accuracy of the blood glucose monitoring device Prestige IQ.
Larbig M; Forst T; Mondok A; Forst S; Pfützner A
Diabetes Nutr Metab; 2003 Aug; 16(4):257-61. PubMed ID: 14768776
[TBL] [Abstract][Full Text] [Related]
33. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
34. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects.
Sachedina N; Pickup JC
Diabet Med; 2003 Dec; 20(12):1012-5. PubMed ID: 14632702
[TBL] [Abstract][Full Text] [Related]
35. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
[TBL] [Abstract][Full Text] [Related]
36. Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes.
Jeha GS; Karaviti LP; Anderson B; Smith EO; Donaldson S; McGirk TS; Haymond MW
Diabetes Care; 2004 Dec; 27(12):2881-6. PubMed ID: 15562201
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of continuous glucose monitoring system to detect unrecognized hypoglycemia in children and adolescents with type 1 diabetes.
Maia FF; Araújo LR
Arq Bras Endocrinol Metabol; 2005 Aug; 49(4):569-74. PubMed ID: 16358087
[TBL] [Abstract][Full Text] [Related]
38. Continuous glucose monitoring system during physical exercise in adolescents with type 1 diabetes.
Adolfsson P; Nilsson S; Lindblad B
Acta Paediatr; 2011 Dec; 100(12):1603-9. PubMed ID: 21711393
[TBL] [Abstract][Full Text] [Related]
39. The MiniMed Continuous Glucose Monitoring System (CGMS).
Mastrototaro J
J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():751-8. PubMed ID: 10626266
[No Abstract] [Full Text] [Related]
40. Prevalence of nocturnal hypoglycemia in pediatric type 1 diabetes: a pilot study using continuous glucose monitoring.
Ahmet A; Dagenais S; Barrowman NJ; Collins CJ; Lawson ML
J Pediatr; 2011 Aug; 159(2):297-302.e1. PubMed ID: 21414634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
